Fig_10.tif (491.65 kB)
TLR agonist treatment induced pro-inflammatory cytokines and NS3 pre-treatment does not induce immune tolerance.
figure
posted on 2015-05-12, 02:50 authored by Ayilam Ramachandran Rajalakshmy, Jambulingam Malathi, Hajib Naraharirao MadhavanMicroglia was exposed to 50 ng/ml of Pam2CSK4 and Pam3CSK4 and pro-inflammatory cytokine expressions were measured by ELISA. (A and B) Pam2CSK4 treatment induced IL-6 and TNF-α production at 3 and 16 hr time point. (C and D) Similarly Pam3CSK4 treatment induced IL-6 and TNF-α production. Microglial cells were pre-treated with 20 ng/ml of NS3 protein for 16 hrs before 6 hr NS3 treatment to study the immune tolerance induction by NS3. (E) There was no significant difference observed for TNF-α production inNS3 exposed and NS3 pre-treated cells. The data is expressed as mean (n = 3) ± SE, *p< 0.05.
History
Usage metrics
Categories
Keywords
NS 3Tumor nicrosis factorHCV NS 3 proteinReceptor Ligand Treatment Furnished Immune Tolerance BackgroundRecent evidenceTLR agonists Pam 3CSKhepatitis C Virus NS 3 Mediated Microglial Inflammationligands Pam 2CSKnfHepatitis C viruselisaNuclear Factor kappaBmicroglial cell line CHME 3.MethodsILNS 3 proteincytokine gene expressioncnstnfNS 3. TLR ligand treatmentfacs
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC